UPDATED Apr 25, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.39 | -3.1% | -39.0% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
WAYS | kr23.40 | -0.2% | -54.8% | kr188.8m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
NVG | zł2.16 | -6.1% | 34.2% | zł75.6m | zł3.71 | PE7.8x | E28.5% | n/a | Diversified Financials | ||
AVLL3 | R$3.50 | -7.7% | 26.4% | R$683.7m | R$9.90 | PS1.4x | E101.9% | n/a | Consumer Durables | ||
RDUE | €9.50 | -0.5% | 2.6% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
AGP | €7.52 | 0% | 100.0% | €130.2m | €12.75 | PE26.5x | E22.8% | n/a | Capital Goods | ||
ALKT | US$23.86 | -0.7% | 98.8% | US$2.3b | US$28.70 | PS8.8x | E80.1% | n/a | Software | ||
ATAKP | ₺47.68 | 5.7% | n/a | ₺6.6b | ₺67.66 | PE22.4x | E72.8% | n/a | Food, Beverage & Tobacco | ||
CALTX | kr104.10 | 2.1% | -15.6% | kr5.6b | kr208.00 | PS4.6x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
FDE | €33.50 | 2.1% | -5.0% | €175.2m | €64.07 | PE22.3x | E32.2% | n/a | Energy | ||
TGTX | US$13.91 | -0.6% | -40.4% | US$2.0b | US$29.75 | PE159.1x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
OSE | €5.60 | 12.0% | 25.6% | €120.8m | €7.15 | PS54.2x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$23.16 | 5.7% | 29.5% | US$2.5b | US$25.50 | PE24.1x | E43.0% | 3.6% | Energy | ||
ZVRA | US$4.52 | 0.4% | -13.2% | US$189.2m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
ESTA | US$48.54 | -7.7% | -29.1% | US$1.3b | US$59.29 | PS8.1x | E65.4% | n/a | Healthcare | ||
PRL | CA$22.37 | 0.6% | 241.0% | CA$767.9m | CA$24.37 | PE20.2x | E33.6% | 2.1% | Diversified Financials | ||
AXSM | US$71.52 | 8.8% | 0.5% | US$3.4b | US$121.13 | PS12.5x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$176.03 | 5.1% | 89.6% | US$9.8b | US$206.21 | PE75.5x | E27.2% | n/a | Household | ||
GWIND | ₺27.90 | 5.7% | 76.3% | ₺15.1b | ₺39.79 | PE24.2x | E60.9% | 1.7% | Utilities | ||
KEBNI B | kr1.57 | 1.8% | 28.4% | kr424.6m | kr1.80 | PS5.9x | E96.2% | n/a | Tech | ||
RCEL | US$8.30 | -6.4% | -45.3% | US$214.1m | US$26.43 | PS4.3x | E61.1% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.23 | -10.8% | 154.8% | US$483.2m | US$11.60 | PS48.4x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
DIRR3 | R$23.16 | 4.0% | 47.5% | R$4.0b | R$28.75 | PE12.1x | E25.1% | 2.0% | Consumer Durables |